Tezepelumab in the Treatment of Uncontrolled Severe Asthma.

Jacqueline FeistMelissa Lipari Pramodini B Kale-Pradhan

Published in: The Annals of pharmacotherapy (2022)

Tezepelumab has shown clinical utility in severe uncontrolled asthma regardless of phenotype, fulfilling the need for treatment options in individuals with severe, uncontrolled, noneosinophilic, and nonallergic asthma.

Keyphrases

chronic obstructive pulmonary disease
lung function
early onset
allergic rhinitis
drug induced
combination therapy